Stocks rally on optimism over U.S.–China trade deal ahead of Trump–Xi meeting.
Gayle King, co-host of CBS Mornings, is expected to leave her role when her contract expires in May 2026, potentially moving to a different or behind-the-scenes position.
Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
Stocks rally on optimism over U.S.–China trade deal ahead of Trump–Xi meeting.
Gayle King, co-host of CBS Mornings, is expected to leave her role when her contract expires in May 2026, potentially moving to a different or behind-the-scenes position.
Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.